Pfizer Inc. (NYSE:PFE)

The financial performance from 2021 to 2025 is characterized by a significant transition from substantial value creation to a period of sustained value destruction. While the initial years showed strong economic gains, a sharp reversal in profitability coupled with an expanded capital base has led to negative economic profit in the latter half of the period.

Net Operating Profit After Taxes (NOPAT)

A pattern of extreme volatility is observed in operating profitability. NOPAT peaked in 2022 at US$ 31,018 million but experienced a severe collapse in 2023, falling to a deficit of US$ 1,277 million. Although a recovery was realized in 2024 and 2025, with values stabilizing around US$ 7,200 million, these levels represent a significant decline compared to the performance seen in 2021 and 2022.

Invested Capital and Cost of Capital

Invested capital underwent a period of aggressive expansion, rising from US$ 87,670 million in 2021 to a peak of US$ 154,882 million in 2023. Despite a moderate reduction in 2024, the capital base remained elevated at US$ 139,753 million by 2025. Meanwhile, the cost of capital remained relatively stable, fluctuating between 8.48% and 9.81%, which indicates that the decline in economic profit was driven by operational performance and capital volume rather than shifts in the required rate of return.

Economic Profit Trends

The economic profit trajectory shows a stark shift from positive to negative territory. After reaching a high of US$ 20,154 million in 2022, the figure plummeted to negative US$ 14,410 million in 2023. The economic profit remained negative through 2024 and 2025, ending at negative US$ 4,897 million. This indicates that the returns generated by NOPAT were insufficient to cover the capital charge associated with the increased invested capital base.

The overall trend suggests that the expansion of invested capital occurred during a period of diminishing operating returns. The inability of NOPAT to return to 2021-2022 levels, despite the recovery from the 2023 trough, has resulted in a persistent state of economic value destruction over the most recent three fiscal years.

Net income attributable to Pfizer Inc. common shareholders and Net Operating Profit After Taxes (NOPAT) exhibited significant fluctuations between 2021 and 2025. While net income demonstrated an initial increase followed by a substantial decline, NOPAT mirrored this pattern with even more pronounced volatility, including a negative value in 2023.

Net Income Trend

Net income attributable to Pfizer Inc. common shareholders increased from US$21,979 million in 2021 to US$31,372 million in 2022, representing a substantial year-over-year growth. However, a dramatic decrease was observed in 2023, falling to US$2,119 million. A partial recovery occurred in 2024, with net income reaching US$8,031 million, followed by a slight decrease to US$7,771 million in 2025.

NOPAT Trend

NOPAT followed a similar trajectory to net income, increasing from US$18,394 million in 2021 to US$31,018 million in 2022. A significant shift occurred in 2023, with NOPAT becoming negative at US$-1,277 million. A recovery was then seen in 2024, rising to US$7,374 million, and continuing to US$7,193 million in 2025. The magnitude of the decline and subsequent recovery in NOPAT was greater than that observed in net income.

Relationship between Net Income and NOPAT

While both metrics generally moved in the same direction, the divergence in 2023 is noteworthy. The substantial negative NOPAT value suggests that operating profits, after accounting for taxes, were insufficient to cover the cost of capital employed during that year, despite a positive, albeit significantly reduced, net income. This indicates that factors beyond core operational profitability, such as financing or non-operating items, played a larger role in determining net income in 2023.

The period between 2024 and 2025 shows relative stabilization in both metrics, although NOPAT remains considerably lower than its peak in 2022. Further investigation would be required to understand the underlying drivers of these fluctuations and their implications for the company’s long-term financial performance.

The provision for taxes on income exhibits significant volatility over the observed period. Beginning at US$1,852 million in 2021, it increased substantially to US$3,328 million in 2022 before experiencing a dramatic shift to a benefit of negative US$1,115 million in 2023. This benefit continued, albeit at a smaller magnitude, in 2024 (-US$28 million) and 2025 (-US$267 million). In contrast, cash operating taxes demonstrate a more stable, though fluctuating, pattern.

Cash Operating Taxes Trend

Cash operating taxes increased from US$6,137 million in 2021 to US$7,967 million in 2022, representing a substantial rise. A subsequent decrease was noted in 2023, falling to US$2,113 million. Values then recovered somewhat in 2024 and 2025, reaching US$2,426 million and US$2,334 million respectively. While fluctuating, the values in 2024 and 2025 remain considerably below the 2021 and 2022 levels.

The divergence between the provision for taxes on income and cash operating taxes is noteworthy. The large benefit recorded in the provision for taxes in 2023, 2024, and 2025 suggests the utilization of tax loss carryforwards or other tax planning strategies, resulting in a reduced accounting expense despite continued cash outflows for taxes. The cash operating taxes, while decreasing from 2022 to 2023, remained positive throughout the period, indicating actual cash payments were made to tax authorities even when the accounting provision reflected a benefit.

Relationship between Provision and Cash Taxes

The difference between the provision for taxes on income and cash operating taxes widened considerably in 2023, 2024, and 2025. This indicates a growing deferral of taxable income or an increasing benefit from tax credits or loss carryforwards. The substantial difference highlights the impact of non-cash tax items on the reported income tax expense.

The observed trends suggest a complex tax position, potentially involving significant tax planning and the utilization of deferred tax assets. Further investigation into the specific drivers of the tax benefit and the nature of the deferred tax items would be beneficial for a complete understanding of the company’s tax strategy and its impact on financial performance.

The reported invested capital demonstrates a clear increasing trend over the observed period, followed by a stabilization and slight increase. A significant rise is noted between 2021 and 2023, while subsequent years show a more moderate pattern. This analysis details the observed movements in invested capital alongside its constituent components: total reported debt & leases and total shareholders’ equity.

Invested Capital Trend

Invested capital increased substantially from US$87,670 million in 2021 to US$154,882 million in 2023, representing a growth of approximately 76.8%. This growth slowed considerably in 2024, with invested capital decreasing to US$135,342 million. A modest increase to US$139,753 million was observed in 2025. The 2024 decrease suggests a potential shift in capital allocation strategy or a reduction in capital-intensive projects.

Debt & Leases

Total reported debt & leases decreased from US$41,395 million in 2021 to US$39,046 million in 2022. However, a substantial increase occurred in 2023, reaching US$75,041 million. This was followed by a decrease to US$66,993 million in 2024 and a slight increase to US$67,416 million in 2025. The 2023 surge in debt likely contributed significantly to the overall increase in invested capital during that year.

Shareholders’ Equity

Total shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022, indicating strong equity growth. A decrease was then observed in 2023, falling to US$89,014 million, and continued to decline in 2024 and 2025, reaching US$88,203 million and US$86,476 million respectively. This consistent decline in shareholders’ equity over the latter part of the period partially offset the impact of increased debt on invested capital.

The interplay between debt and equity significantly influences the overall invested capital. While debt increased substantially in 2023, the subsequent decrease in shareholders’ equity moderated the growth in invested capital in 2024 and 2025. The stabilization of invested capital in the later years suggests a balancing act between debt financing and equity returns.

The financial performance concerning economic value generation exhibits a significant transition from substantial value creation to a period of sustained value destruction between 2021 and 2025. A period of peak profitability in 2022 was followed by a sharp reversal, leading to negative economic outcomes in the subsequent three years.

Economic Profit Trends

Economic profit experienced a sharp increase from US$ 9,964 million in 2021 to a peak of US$ 20,154 million in 2022. However, a severe downturn occurred in 2023, with profit plummeting to a deficit of US$ 14,410 million. While the deficit narrowed to US$ 4,314 million in 2024, it widened slightly again to US$ 4,897 million by the end of 2025, indicating a persistent inability to generate returns above the cost of capital.

Invested Capital Dynamics

Invested capital showed a consistent upward trajectory from 2021 to 2023, rising from US$ 87,670 million to a peak of US$ 154,882 million. A contraction followed in 2024 to US$ 135,342 million, before stabilizing at US$ 139,753 million in 2025. This expansion of the capital base through 2023 coincided with the eventual decline in economic profitability.

Economic Spread Ratio Analysis

The economic spread ratio mirrors the volatility of economic profit. The ratio improved from 11.36% in 2021 to a high of 18.20% in 2022, signaling strong value creation. A drastic collapse to -9.30% occurred in 2023, representing a shift toward value destruction. Although the ratio improved to -3.19% in 2024, it remained negative through 2025 at -3.50%, confirming that the return on invested capital remained below the required hurdle rate during the final three years of the period.

The financial trajectory from 2021 to 2025 is characterized by a period of exceptional growth followed by a sharp contraction and a subsequent transition into a state of economic value destruction. A performance peak was reached in 2022, after which a significant reversal occurred in 2023, leading to persistent negative economic returns through 2025.

Revenue Volatility

Revenues exhibited a sharp increase between 2021 and 2022, rising from US$ 82,145 million to a peak of US$ 101,175 million. This growth was followed by a precipitous decline in 2023, where revenues fell to US$ 59,553 million, a reduction of approximately 41% from the previous year. For the remainder of the period, revenues stabilized within a narrow range, recording US$ 63,627 million in 2024 and US$ 62,579 million in 2025.

Economic Profit Trends

Economic profit demonstrated a mirrored pattern to revenues, surging from US$ 9,964 million in 2021 to US$ 20,154 million in 2022, indicating significant value creation above the cost of capital. A severe downturn occurred in 2023, as economic profit shifted to a deficit of US$ 14,410 million. Although a recovery was observed in 2024 with the deficit narrowing to US$ 4,314 million, the trend reversed slightly in 2025, with economic profit ending at negative US$ 4,897 million.

Economic Profit Margin Analysis

The economic profit margin expanded from 12.13% in 2021 to a peak of 19.92% in 2022, reflecting optimal capital efficiency. This was followed by a collapse to -24.20% in 2023, signaling that returns on invested capital fell substantially below the required cost of capital. The margin showed a corrective trend in 2024, rising to -6.78%, before experiencing a slight deterioration to -7.82% in 2025, confirming a sustained period of value erosion.